78
Views
17
CrossRef citations to date
0
Altmetric
Article

Id3 Orchestrates Germinal Center B Cell Development

, , , , &
Pages 2543-2552 | Received 11 Mar 2016, Accepted 18 Jul 2016, Published online: 17 Mar 2023

REFERENCES

  • Victora GD, Nussenzweig MC. 2012. Germinal centers. Annu Rev Immunol 30:429–457. http://dx.doi.org/10.1146/annurev-immunol-020711-075032.
  • Chandra V, Bortnick A, Murre C. 2015. AID targeting: old mysteries and new challenges. Trends Immunol 36:527–535. http://dx.doi.org/10.1016/j.it.2015.07.003.
  • Teng G, Papavasiliou FN. 2007. Immunoglobulin somatic hypermutation. Annu Rev Genet 41:107–120. http://dx.doi.org/10.1146/annurev.genet.41.110306.130340.
  • Xu Z, Zan H, Pon EJ, Mai T, Casali P. 2012. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol 12:517–531. http://dx.doi.org/10.1038/nri3216.
  • Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553–563. http://dx.doi.org/10.1016/S0092-8674(00)00078-7.
  • Rothenberg EV. 2014. Transcriptional control of early T and B cell developmental choices. Annu Rev Immunol 32:283–321. http://dx.doi.org/10.1146/annurev-immunol-032712-100024.
  • Bain G, Murre C. 1998. The role of E-proteins in B- and T-lymphocyte development. Semin Immunol 10:143–153. http://dx.doi.org/10.1006/smim.1998.0116.
  • Murre C, McCaw PS, Baltimore D. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer, daughterless, MyoD and myc proteins. Cell 56:777–783. http://dx.doi.org/10.1016/0092-8674(89)90682-X.
  • Mansson R, Welinder E, Ashber J, Lin YC, Benner C, Glass CK, Sigvardsson M, Murre C. 2012. Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate. Proc Natl Acad Sci U S A 109:21028–21033. http://dx.doi.org/10.1073/pnas.1211427109.
  • Beck K, Peak M, Ota T, Nemazee Murre DC. 2009. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J Exp Med 206:2271–2284. http://dx.doi.org/10.1084/jem.20090756.
  • Kwon K, Hutter C, Sun Q, Bilic I, Cobaleda C, Malin S, Busslinger M. 2008. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28:751–762. http://dx.doi.org/10.1016/j.immuni.2008.04.014.
  • Sayegh CE, Quong MW, Agata Y, Murre C. 2003. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 4:586–593. http://dx.doi.org/10.1038/ni923.
  • Tran TH, Nakata M, Suzuki K, Begum NA, Shinkura R, Fagarasan S, Honjo T, Nagaoka H. 2010. B cell specific and stimulation-responsive enhancers depresses Aicda by overcoming the effects of silencers. Nat Immunol 11:148–154. http://dx.doi.org/10.1038/ni.1829.
  • Benezra R, Davis RL, Lockshon D, Turner DL, Weintaub H. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49–59. http://dx.doi.org/10.1016/0092-8674(90)90214-Y.
  • Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S, Gruss P. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix protein Id2. Nature 397:702–706. http://dx.doi.org/10.1038/17812.
  • Agata Y, Tamaki N, Sakamoto S, Ikawa T, Masuda K, Kawamoto H, Murre C. 2007. Regulation of T cell receptor beta gene rearrangements and allelic exclusion by the helix-loop-helix protein, E47. Immunity 27:871–884. http://dx.doi.org/10.1016/j.immuni.2007.11.015.
  • Miyazaki M, Rivera RR, Miyazaki K, Lin C, Agata Y, Murre C. 2011. The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naïve fate of T cells. Nat Immunol 12:992–1001. http://dx.doi.org/10.1038/ni.2086.
  • Lauritsen JP, Wong GW, Lee SY, Lefebvre JM, Ciofani M, Rhodes M, Kappes DJ, Zúñiga-Pflücker JC, Wiest DL. 2009. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity 31:565–575. http://dx.doi.org/10.1016/j.immuni.2009.07.010.
  • Li J, Wu D, Jiang N, Zhuang Y. 2013. Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion. J Immunol 191:5052–5064. http://dx.doi.org/10.4049/jimmunol.1301252.
  • Miyazaki M, Miyazaki K, Chen SY, Chandra V, Agata Y, Chang A, Kawamoto H, Murre C. 2015. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion and lymphomagenesis. Genes Dev 29:409–425. http://dx.doi.org/10.1101/gad.255331.114.
  • Liu X, Chen X, Zhong B, Wang A, Wang X, Chu F, Nurieva RI, Yan X, Chen P, van der Flier LG, Nakatsukasa H, Neelapu SS, Chen W, Clevers H, Tian Q, Qi H, Wei L, Dong C. 2014. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 507:513–518. http://dx.doi.org/10.1038/nature12910.
  • Ueda-Hayakawa I, Mahlios J, Zhuang Y. 2009. Id3 restricts the developmental potential of gamma delta lineage during thymopoiesis. J Immunol 182:5306–5316. http://dx.doi.org/10.4049/jimmunol.0804249.
  • Verykokakis M, Krishnamoorth V, Iavarone A, Lasorella A, Sigvardsson M. 2013. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J Immunol 191:5973–5983. http://dx.doi.org/10.4049/jimmunol.1301521.
  • Jones-Mason ME, Zhao X, Kappes D, Lasorella A, Iavarone A, Zhuang Y. 2012. E protein transcription factors are required for the development of CD4(+) lineage T cells. Immunity 36:348–361. http://dx.doi.org/10.1016/j.immuni.2012.02.010.
  • Alonzo ES, Sant'Angelo DB. 2011. Development of PLZF-expressing innate T cells. Curr Opin Immunol 23:220–227. http://dx.doi.org/10.1016/j.coi.2010.12.016.
  • D'Cruz LM, Stradner MH, Yang CY, Goldrath AW. 2014. E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol 192:2227–2236. http://dx.doi.org/10.4049/jimmunol.1302904.
  • Murre C. 2005. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 6:1079–1086. http://dx.doi.org/10.1038/ni1260.
  • Rickert RC, Roes J, Rajewsky K. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25:1317–1318. http://dx.doi.org/10.1093/nar/25.6.1317.
  • Calado DP, Zhang B, Srinivasan L, Sasaki Y, Seagal J, Unitt C, Rodig S, Kutok J, Tarakhovsky A, Schmidt-Supprian M, Rajewsky K. 2010. Constitutive canonical NF-kB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell 18:580–589. http://dx.doi.org/10.1016/j.ccr.2010.11.024.
  • Guo Z, Li H, Han M, Xu T, Wu X, Zhuang Y. 2011. Modeling Sjogren's syndrome with id3 conditional knockout mice. Immunol Lett 135:34–42. http://dx.doi.org/10.1016/j.imlet.2010.09.009.
  • Cumano A, Rajewsky K. 1985. Structure of primary anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idiotypically suppressed C57BL/6 mice. Eur J Immunol 15:512–520. http://dx.doi.org/10.1002/eji.1830150517.
  • Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65:109–121. http://dx.doi.org/10.1016/0022-1759(83)90308-3.
  • Carayon P, Bord A. 1992. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J Immunol Methods 147:225–230. http://dx.doi.org/10.1016/S0022-1759(12)80012-3.
  • Fisch K, Meissner T, Gioia L, Ducom J-C, Carland T, Loguercio S, Su A. 2015. Omics Pipe: a community-based framework for reproducible multi-omics data analysis. Bioinformatics 31:1724–1728. http://dx.doi.org/10.1093/bioinformatics/btv061.
  • Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, Robinson MD. 2013. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protoc 8:1765–1786. http://dx.doi.org/10.1038/nprot.2013.099.
  • Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. http://dx.doi.org/10.1093/bioinformatics/bts635.
  • Chen J, Bardes EE, Aronow BJ, Jegga AG. 2009. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37:W305–W311. http://dx.doi.org/10.1093/nar/gkp427.
  • Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550–558. http://dx.doi.org/10.1186/s13059-014-0550-8.
  • Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y. 1999. Impaired immune responses and B cell proliferation in mice lacking the Id3 gene. Mol Cell Biol 19:5969–5980. http://dx.doi.org/10.1128/MCB.19.9.5969.
  • Quong M, Martensson A, Langerak AW, Rivera RR, Nemazee D, Murre C. 2004. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J Exp Med 199:1101–1112. http://dx.doi.org/10.1084/jem.20031180.
  • Quong MW, Harris DP, Swain SL, Murre C. 1999. E2A activity is induced during B cell activation to promote immunoglobulin class switch recombination. EMBO J 18:6307–6318. http://dx.doi.org/10.1093/emboj/18.22.6307.
  • Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Staudt LM. 2012. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116–120. http://dx.doi.org/10.1038/nature11378.
  • Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Dave SS. 2012. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321–1325. http://dx.doi.org/10.1038/ng.2468.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.